These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 7812011

  • 1. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.
    Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler RE.
    Blood; 1995 Jan 15; 85(2):552-65. PubMed ID: 7812011
    [Abstract] [Full Text] [Related]

  • 2. Molecular pathology of posttransplantation lymphoproliferative disorders.
    Chadburn A, Cesarman E, Knowles DM.
    Semin Diagn Pathol; 1997 Feb 15; 14(1):15-26. PubMed ID: 9044506
    [Abstract] [Full Text] [Related]

  • 3. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.
    Cesarman E, Chadburn A, Liu YF, Migliazza A, Dalla-Favera R, Knowles DM.
    Blood; 1998 Oct 01; 92(7):2294-302. PubMed ID: 9746767
    [Abstract] [Full Text] [Related]

  • 4. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
    Quintanilla-Martínez L, Lome-Maldonado C, Schwarzmann F, Gredler E, Reyes E, Angeles-Angeles A, Fend F.
    Mod Pathol; 1998 Feb 01; 11(2):200-8. PubMed ID: 9504692
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
    Scheinfeld AG, Nador RG, Cesarman E, Chadburn A, Knowles DM.
    Am J Pathol; 1997 Sep 01; 151(3):805-12. PubMed ID: 9284829
    [Abstract] [Full Text] [Related]

  • 8. Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features.
    Orazi A, Hromas RA, Neiman RS, Greiner TC, Lee CH, Rubin L, Haskins S, Heerema NA, Gharpure V, Abonour R, Srour EF, Cornetta K.
    Am J Clin Pathol; 1997 Apr 01; 107(4):419-29. PubMed ID: 9124210
    [Abstract] [Full Text] [Related]

  • 9. Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders.
    Nador RG, Chadburn A, Gundappa G, Cesarman E, Said JW, Knowles DM.
    Am J Surg Pathol; 2003 Mar 01; 27(3):293-302. PubMed ID: 12604885
    [Abstract] [Full Text] [Related]

  • 10. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.
    Frank D, Cesarman E, Liu YF, Michler RE, Knowles DM.
    Blood; 1995 Mar 01; 85(5):1396-403. PubMed ID: 7858270
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M.
    Blood; 1996 Jul 01; 88(1):242-51. PubMed ID: 8704180
    [Abstract] [Full Text] [Related]

  • 12. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
    Knecht H, Martius F, Bachmann E, Hoffman T, Zimmermann DR, Rothenberger S, Sandvej K, Wegmann W, Hurwitz N, Odermatt BF.
    Leukemia; 1995 Mar 01; 9(3):458-65. PubMed ID: 7885044
    [Abstract] [Full Text] [Related]

  • 13. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M, Morita Y, Nakamura N, Shimizu K, Murayama K, Nakamura S.
    Pathol Res Pract; 2008 Mar 01; 204(4):267-72. PubMed ID: 18187262
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-associated large-cell lymphomas. Case report.
    Kingma DW, Shad A, Tsokos M, Fest T, Otsuki T, Frekko K, Werner E, Werner A, Magrath I, Raffeld M, Jaffe ES.
    Am J Surg Pathol; 1996 Dec 01; 20(12):1511-9. PubMed ID: 8944045
    [Abstract] [Full Text] [Related]

  • 19. Immunodeficiency-associated lymphoproliferative disorders.
    Knowles DM.
    Mod Pathol; 1999 Feb 01; 12(2):200-17. PubMed ID: 10071343
    [Abstract] [Full Text] [Related]

  • 20. Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.
    Oudejans JJ, Jiwa M, van den Brule AJ, Grässer FA, Horstman A, Vos W, Kluin PM, van der Valk P, Walboomers JM, Meijer CJ.
    Am J Pathol; 1995 Oct 01; 147(4):923-33. PubMed ID: 7573368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.